Consequently, the OncoScan array detected mutations in the TP53 gene for 14/47 tumors, of which 8 were identified in BC (33% of the BCs), 2 in MM (22% of the group of MM), and 2 in HM (50% of the HM; Figure 2 and Table S3). The gene discussed is TP53; the disease is breast cancer.